NOETIK
LIVE

Serial Number

98159529

Owner

Noetik Inc.

Attorney

Alyssa M. Worsham

Filing Date

Aug 31, 2023

Add to watchlist:

No watchlists yet
View on USPTO

NOETIK Trademark

Serial Number: 98159529

NOETIK is a trademark filed by Noetik Inc. on August 31, 2023. The trademark is classified under Class 1 (Chemicals), Class 9 (Computers & Electronics), Class 42 (Computer & Scientific). The application is currently pending registration.

Owner Contact Info

Noetik Inc.

2 Tower Place, 17th Floor
San Francisco, CA 94080

Entity Type: 03

Trademark Details

Filing Date

August 31, 2023

Registration Date

Not Registered

Published for Opposition

June 4, 2024

Goods & Services

Biochemicals for in vitro and in vivo scientific use; biological preparations for use in industry and science; chemical preparations for scientific purposes; reagents for scientific and research use; reagents for scientific or medical research use

Downloadable computer software incorporating machine learning technology for the purpose of facilitating medical and scientific research and development; downloadable computer software for the purpose of conducting medical and scientific research and development; downloadable application programming interface (API) software; downloadable computer software for generating petabytes of multimodel spatial data for use in connection with machine learning technology for the purpose of scientific and medical research and development; downloadable computer machine learning software for the purpose of accelerating medical and scientific research; downloadable computer software using machine learning technology to improve molecular training for the purpose of tumor profiling for use in the field of oncology; downloadable computer software for processing biospecimens and conducting tissue arraying for the purpose of generating multimodel data using computational biology and machine learning technology; downloadable computer software for creating and interpreting machine learning models for tumor profiling

pharmaceutical and therapeutics research and development services; research and development in the therapeutics, pharmaceutical and biotechnology fields; biotechnology research services; research and product development in the field of human therapeutics; providing a website featuring research and development information in the therapeutics, pharmaceutical and biotechnology fields; medical and pharmaceutical research services; pharmaceutical research and development; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; medical and scientific research, namely, conducting clinical trials for others; laboratory research services relating to pharmaceuticals; scientific and technological services, namely, scientific research services in the field of process development, validation, qualification, and manufacturing of pharmaceuticals and biopharmaceuticals; scientific research and technological services consultation services in the field of development, manufacturing and testing of pharmaceuticals and biopharmaceuticals; providing product research and development in the pharmaceutical field for purposes of process development, validation, qualification, and manufacturing of pharmaceuticals and biopharmaceuticals; scientific research and technological consultation services in the field of pharmaceutical research and pharmacology; custom development of pharmaceutical, biopharmaceutical and chemical products; pre-clinical and non-clinical evaluation testing of pharmaceutical, biopharmaceutical and chemical products performed primarily using biological models; pharmaceutical, biopharmaceutical, and chemical research and development for others; pharmaceutical research in the field of oncology; pharmaceutical research for the treatment of infectious, deficiency, hereditary, and physiological diseases; research and development of platform technologies for delivery of therapies; providing temporary use of non-downloadable computer software incorporating machine learning technology for the purpose of facilitating medical and scientific research and development; providing temporary use of non-downloadable computer software for the purpose of conducting medical and scientific research and development; proving temporary use of non-downloadable application programming interface (API) software; providing temporary use of non-downloadable computer software for generating petabytes of multimodel spatial data for use in connection with machine learning technology for the purpose of scientific and medical research and development; providing temporary use of non-downloadable computer machine learning software for the purpose of accelerating medical and scientific research; providing temporary use of non-downloadable computer software using machine learning technology to improve molecular training for the purpose of tumor profiling for use in the field of oncology; providing temporary use of non-downloadable computer software for processing biospecimens and conducting tissue arraying for the purpose of generating multimodel data using computational biology and machine learning technology; providing temporary use of non-downloadable computer software for creating and interpreting machine learning models for tumor profiling

Filing History

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jan 23, 2026 EXRA
SOU EXTENSION 3 GRANTED
Jan 23, 2026 EX3G
SOU EXTENSION 3 FILED
Jan 22, 2026 EXT3
SOU TEAS EXTENSION RECEIVED
Jan 22, 2026 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jul 22, 2025 EXRA
SOU EXTENSION 2 GRANTED
Jul 21, 2025 EX2G
SOU EXTENSION 2 FILED
Jul 21, 2025 EXT2
SOU TEAS EXTENSION RECEIVED
Jul 21, 2025 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Mar 4, 2025 EXRA
SOU EXTENSION 1 GRANTED
Jan 11, 2025 EX1G
SOU EXTENSION 1 FILED
Jan 10, 2025 EXT1
SOU TEAS EXTENSION RECEIVED
Jan 10, 2025 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Jul 30, 2024 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jun 4, 2024 NPUB
PUBLISHED FOR OPPOSITION
Jun 4, 2024 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
May 15, 2024 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 30, 2024 CNSA
ASSIGNED TO EXAMINER
Apr 29, 2024 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 27, 2023 NWOS
NEW APPLICATION ENTERED
Sep 4, 2023 NWAP